Recent 13F filings as of December 2025 show that 99 institutional investors hold a position in Sangamo Therapeutics, Inc (NASDAQ:SGMO).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 12,000,383 | 385,233 | 3.32% | $5,040,161.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 8,430,323 | -1,752,140 | -17.21% | $3,540,736.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 4,755,995 | 2,276,809 | 91.84% | $1,997,518.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 4,571,786 | 15,578 | 0.34% | $1,920,150.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 4,343,255 | 2,234,900 | 106.00% | $1,824,167.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 3,866,026 | 579,550 | 17.63% | $1,624,115.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 3,045,827 | 796,942 | 35.44% | $1,279,248.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 2,137,120 | -283,246 | -11.70% | $897,590.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 1,713,331 | 174,333 | 11.33% | $719,599.00 |
| WASATCH ADVISORS LP | 31 Dec, 2025 | 1,416,717 | -9,736 | -0.68% | $595,021.00 |
| STATE STREET CORP | 31 Dec, 2025 | 1,355,583 | 0 | 0.00% | $569,345.00 |
| LUMINUS MANAGEMENT LLC | 31 Dec, 2025 | 1,158,761 | 908,761 | 363.50% | $486,680.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31 Dec, 2025 | 1,050,714 | 204,181 | 24.12% | $441,300.00 |
| UBS Group AG | 31 Dec, 2025 | 1,024,475 | -296,343 | -22.44% | $430,280.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 737,867 | 98,187 | 15.35% | $309,904.00 |
| HighTower Advisors, LLC | 31 Dec, 2025 | 704,456 | -39,650 | -5.33% | $295,872.00 |
| GROUP ONE TRADING LLC | 31 Dec, 2025 | 500,179 | -1,825 | -0.36% | $210,075.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 423,752 | -168,401 | -28.44% | $177,975.00 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 31 Dec, 2025 | 400,000 | 400,000 | 0.00% | $168,000.00 |
| Golden State Equity Partners | 31 Dec, 2025 | 395,943 | -23,000 | -5.49% | $166,296.00 |